162 related articles for article (PubMed ID: 36015203)
1. Development and Comparison of Various Coated Hard Capsules Suitable for Enteric Administration to Small Patient Cohorts.
Fülöpová N; Pavloková S; DeBono I; Vetchý D; Franc A
Pharmaceutics; 2022 Jul; 14(8):. PubMed ID: 36015203
[TBL] [Abstract][Full Text] [Related]
2. Pharmaceutical development of enteric-release hard gelatin capsules in the compounding setting.
Ferreira Ade O; Holandino C
Int J Pharm Compd; 2008; 12(2):163-9. PubMed ID: 23969610
[TBL] [Abstract][Full Text] [Related]
3. Coated capsules for drug targeting to proximal and distal part of human intestine.
Dvorácková K; Rabisková M; Gajdziok J; Vetchý D; Muselík J; Bernatoniene J; Bajerová M; Drottnerová P
Acta Pol Pharm; 2010; 67(2):191-9. PubMed ID: 20369797
[TBL] [Abstract][Full Text] [Related]
4. Commercially Available Enteric Empty Hard Capsules, Production Technology and Application.
Franc A; Vetchý D; Fülöpová N
Pharmaceuticals (Basel); 2022 Nov; 15(11):. PubMed ID: 36422528
[TBL] [Abstract][Full Text] [Related]
5. Exploring Immersion Coating as a Cost-Effective Method for Small-Scale Production of Enteric-Coated Gelatin Capsules.
Sabbatini B; Perinelli DR; Palmieri GF; Cespi M; Bonacucina G
Pharmaceuticals (Basel); 2024 Mar; 17(4):. PubMed ID: 38675394
[TBL] [Abstract][Full Text] [Related]
6. Enteric coated HPMC capsules designed to achieve intestinal targeting.
Cole ET; Scott RA; Connor AL; Wilding IR; Petereit HU; Schminke C; Beckert T; Cadé D
Int J Pharm; 2002 Jan; 231(1):83-95. PubMed ID: 11719017
[TBL] [Abstract][Full Text] [Related]
7. Enteric coating of nanostructured lipid carriers (NLCs) and enteric coating of hard gelatin capsules filled with NLCs: Feasibility studies.
Managuli RS; Reddy MS; Koteshwara KB; Mutalik S
Pak J Pharm Sci; 2021 Jul; 34(4):1323-1331. PubMed ID: 34799304
[TBL] [Abstract][Full Text] [Related]
8. Accelerating the dissolution of enteric coatings in the upper small intestine: evolution of a novel pH 5.6 bicarbonate buffer system to assess drug release.
Varum FJ; Merchant HA; Goyanes A; Assi P; Zboranová V; Basit AW
Int J Pharm; 2014 Jul; 468(1-2):172-7. PubMed ID: 24727141
[TBL] [Abstract][Full Text] [Related]
9. Alternative method for enteric coating of HPMC capsules resulting in ready-to-use enteric-coated capsules.
Huyghebaert N; Vermeire A; Remon JP
Eur J Pharm Sci; 2004 Apr; 21(5):617-23. PubMed ID: 15066662
[TBL] [Abstract][Full Text] [Related]
10. Achieving gastroresistance without coating: Formulation of capsule shells from enteric polymers.
Barbosa JAC; Al-Kauraishi MM; Smith AM; Conway BR; Merchant HA
Eur J Pharm Biopharm; 2019 Nov; 144():174-179. PubMed ID: 31541663
[TBL] [Abstract][Full Text] [Related]
11. Formulation of Broccoli Sprout Powder in Gastro-Resistant Capsules Protects against the Acidic pH of the Stomach In Vitro but Does Not Increase Isothiocyanate Bioavailability In Vivo.
Zawari M; Poller B; Walker G; Pearson A; Hampton M; Carr AC
Antioxidants (Basel); 2019 Sep; 8(9):. PubMed ID: 31480621
[TBL] [Abstract][Full Text] [Related]
12. Industrial Manufacture of Enteric Hard Capsules Using Novel Formulations Based on Hypromellose Phthalate/Gelatin and Investigation of Pantoprazole Release.
Kalmer RR; Haddadan MM; Azizi M; Ghanbari M; Samandarian D; Sadjadinia A; Ramezanalizadeh H; Karimi A; Golizadeh M
ACS Omega; 2023 Mar; 8(12):11293-11303. PubMed ID: 37008088
[TBL] [Abstract][Full Text] [Related]
13. Effects of coating layer and release medium on release profile from coated capsules with Eudragit FS 30D: an in vitro and in vivo study.
Moghimipour E; Rezaei M; Kouchak M; Fatahiasl J; Angali KA; Ramezani Z; Amini M; Dorkoosh FA; Handali S
Drug Dev Ind Pharm; 2018 May; 44(5):861-867. PubMed ID: 29235889
[TBL] [Abstract][Full Text] [Related]
14. Coated hard capsules as the pH-dependent drug transport systems to ileo-colonic compartment.
Dvořáčková K; Rabišková M; Muselík J; Gajdziok J; Bajerová M
Drug Dev Ind Pharm; 2011 Oct; 37(10):1131-40. PubMed ID: 21417619
[TBL] [Abstract][Full Text] [Related]
15. In Vitro Evaluation of Enteric-Coated HPMC Capsules-Effect of Formulation Factors on Product Performance.
Fu M; Blechar JA; Sauer A; Al-Gousous J; Langguth P
Pharmaceutics; 2020 Jul; 12(8):. PubMed ID: 32717908
[TBL] [Abstract][Full Text] [Related]
16. Surviving process and transit: Controlled freeze drying, storage and enteric coated capsules for targeted delivery of probiotic
Fredua-Agyeman M
Heliyon; 2024 Apr; 10(7):e28407. PubMed ID: 38560212
[TBL] [Abstract][Full Text] [Related]
17. Polymer film formulations for the preparation of enteric pharmaceutical capsules.
Smith AM; Ingham A; Grover LM; Perrie Y
J Pharm Pharmacol; 2010 Feb; 62(2):167-72. PubMed ID: 20487195
[TBL] [Abstract][Full Text] [Related]
18. A simple and inexpensive enteric-coated capsule for delivery of acid-labile macromolecules to the small intestine.
Miller DS; Parsons AM; Bresland J; Herde P; Pham DM; Tan A; Hsu HY; Prestidge CA; Kuchel T; Begg R; Aziz SM; Butler RN
J Zhejiang Univ Sci B; 2015 Jul; 16(7):586-92. PubMed ID: 26160716
[TBL] [Abstract][Full Text] [Related]
19. Production of enteric capsules by means of hot-melt extrusion.
Mehuys E; Remon JP; Vervaet C
Eur J Pharm Sci; 2005 Feb; 24(2-3):207-12. PubMed ID: 15661492
[TBL] [Abstract][Full Text] [Related]
20. Formulation and in vitro and in vivo availability of diclofenac sodium enteric-coated beads.
Hosny EA; el-Mahrouk GM; Gouda MW
Drug Dev Ind Pharm; 1998 Jul; 24(7):661-6. PubMed ID: 9876511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
